Addus HomeCare (ADUS) Q3 2026 earnings review
Addus profit rises 17% and a major deal expands sales
Addus HomeCare, a provider of in-home aides and clinical care, grew profit much faster than sales and signed the large acquisition it has prepared for all year. Third-quarter revenue rose 7% to $388 million, while profit per share excluding one-offs climbed 17% as office overhead and interest bills fell. Chief executive Dirk Allison also announced a $275 million deal to buy AccentCare's personal care business outside New York, which will expand yearly sales by nearly 19%.
| Revenue | $387.7M +7.0% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $1.83 +17.3% from a year ago |
| Personal Care underlying sales | +6.9% from a year ago |
| AccentCare purchase (announced) | $275M adds ~$280M in yearly sales |
⚖️ Verdict: 🟢 Bullish
The story got better because Addus put its debt-free balance sheet to work on a major acquisition just as its small home health unit returned to underlying growth after a two-year slump. One caution: the core personal care business still leaned on a 5% hourly rate boost for its revenue growth, while the number of patients at existing offices slipped slightly from both last quarter and last year.
The question now is whether rising caregiver fill rates and the new AccentCare branches can offset slowing state payment rate increases in 2027. If patient counts turn up, underlying sales can stay near 6%; if they stay flat, growth will cool toward 4% as last year's Texas and Illinois rate hikes pass their anniversaries. Fourth-quarter same-store patient census and the AccentCare profit details on the call will tell.
🐂 Bull Case
AccentCare Deal Adds 19% More Revenue
Addus provides non-medical home aides alongside clinical hospice and home health care, and it has paid down debt for two years to prepare for a large purchase. In September, the company agreed to buy the personal care division of AccentCare outside New York for about $275 million. Chief executive Dirk Allison said the deal adds about $280 million in yearly revenue, "substantially expanding our capabilities across key states like Texas, Illinois, California, and Arizona".
The deal matters because state payment rate increases are starting to slow down, so Addus needs new volume to keep growing near its 10% yearly goal. By our math, the purchase price equals roughly 1.0 times the acquired division's yearly sales, and Addus can pay for the entire deal using its $98.5 million in cash and $617.8 million in available credit. One risk is that large purchases carry integration costs and push up debt.
What to watch: the closing date and the profit margin of the AccentCare operations on the next earnings call. A margin near Addus's own 13.2% would mean the deal lifts profit per share right away.
Lower Overhead and Debt Lifted Profit
"Disciplined cost controls and operating leverage drove meaningful adjusted EBITDA and net income expansion," chief executive Dirk Allison said. EBITDA is earnings before interest, taxes, depreciation and amortization. In the third quarter, revenue rose 7.0% from a year ago, while profit per share excluding one-offs (such as $3.9 million in deal costs and $3.0 million in stock pay) climbed 17.3% to $1.83.
- General and administrative overhead: 20.7% of revenue, down 1.2 percentage points from 21.9% a year ago by our math
- Gross margin (profit after direct caregiver pay): 32.1%, down 0.1 percentage points from 32.2%
- EBITDA margin excluding one-offs: 13.2% of revenue, up 0.8 percentage points from 12.5% a year ago by our math
- Net interest expense: $0.7 million, down from $2.6 million a year ago after debt paydowns
The cost discipline is real because office overhead grew only 1.4% while sales rose 7.0%, which lifted operating profit by 1.2 percentage points of revenue to 10.3%. Lower interest bills added another boost to the bottom line, though borrowing for the $275 million AccentCare purchase will push interest costs back up once the deal closes.
What to watch: full-year EBITDA margin excluding one-offs in the fourth-quarter report. Finishing near 13% would beat the middle of management's 12% to 13% full-year target.
Home Health Grew for the First Time
Home Health — skilled nursing and therapy in a patient's home, which brings in 4.6% of total revenue — had shrunk at locations owned a year ago in every quarter for two years. In the third quarter, underlying sales in the unit grew 2.5% from a year ago, which Allison called "showing encouraging admission and volume trends and a return to year over year organic revenue growth".
New patient admissions at existing locations rose 13.8% from a year ago to 5,043, and total patient volume rose 11.5% to 7,827. Because this is only the first positive quarter after a long slump, it eases the concern about the unit rather than settling it. Still, growing admissions help Addus refer more patients internally into its larger hospice business.
What to watch: fourth-quarter Home Health underlying sales growth. A second straight quarter of growth would confirm the turnaround in the clinical unit.
🐻 Bear Case
Personal Care Patient Counts Fell Slightly
Personal Care — everyday help with bathing, meals and dressing — accounts for 77.6% of Addus's revenue. Management wants to return the segment's existing locations to patient growth during the second half of 2026. In the third quarter, sales from Personal Care locations owned a year ago rose 6.9%, supported by "ongoing benefits from historical favorable rate adjustments in core states like Illinois, Texas, and New Mexico", Allison said.
- Same-store average billable census (patients served): 49,848, down 0.4% from a year ago and down 107 patients from last quarter by our math
- Revenue per billable hour: $26.67, up 5.0% from $25.40 a year ago by our math
- Total billable hours per business day: 171,004, up 4.0% from a year ago (including acquisitions)
This matters because the 5.0% jump in hourly payment rates did most of the work, while the number of patients at existing offices slipped from both last year and last quarter. Texas raised rates by 9.9% in September 2025 and Illinois raised rates by 3.9% in January 2026; as those increases pass their one-year mark, underlying sales growth will slow unless patient counts start rising.
What to watch: fourth-quarter Personal Care same-store patient census. A drop below 50,037 would mean the company missed its goal of returning to year-over-year patient growth in the second half.
Longer Hospice Stays Hold Back Reported Sales
Allison said the hospice unit — end-of-life care that makes up 17.8% of sales — "contributed strong growth", pointing to an 8.8% underlying sales increase after stripping out prior-year billing adjustments. Yet total reported hospice revenue barely moved at $69.0 million, up just 0.2% from $68.9 million a year ago by our math, and as-reported underlying revenue rose 4.1%.
The gap exists becauseAddus's organic definitions exclude Medicare cap charges (penalties when patients stay too long) and price concessions. Average daily census rose 4.3% to 4,037, but new admissions grew only 0.5% to 3,344 while the average discharged patient stay jumped 21.4% to 108.8 days by our math. Longer stays push branches closer to Medicare billing limits, which held effective revenue per patient day to $185.84 against the $190.36 headline rate.
What to watch: hospice segment profit and Medicare cap charges in the quarterly filing. Further cap charges in the fourth quarter would contradict management's prior statement that cap exposure was finished for 2026.
Risks This Quarter Didn't Answer
Several standing policy, labor and volume questions cannot be read from the earnings release alone and await the conference call or the quarterly filing.
- Personal Care same-store hours per business day growth: not in the release; the conference call will show whether it stayed inside management's 2.0% to 2.5% target.
- Illinois elderly care waiver: the program behind Addus's largest payer was due for federal renewal on September 30, 2026; the quarterly filing will confirm its status.
- New Mexico rate pass-through: management previously targeted a roughly 4% rate increase from managed-care negotiations in the third quarter; the call will clarify how much was finalized.
- Federal Medicaid rules and nursing supply: 2028 federal funding caps, the 2030 rule requiring 80% of payments to go to caregiver wages, and urban nursing shortages remain unaddressed in the release.
👓 Other Themes
Operational Programs Awaiting Call Updates
Two internal growth initiatives received no numerical update in the press release. Addus is rolling out a caregiver scheduling app in Texas after reaching over 90% adoption in Illinois, which lifted the share of authorized hours filled to 84–85% last quarter. The company is also moving its Personal Care offices onto the HomeCare HomeBase software system by early 2027 to track patient referrals across its three care lines.
💲 Other KPIs
Accounts receivable — money owed by state agencies and insurers — rose 20.0% from a year ago and 10.8% from last quarter, outpacing the 7.0% revenue increase. Because more cash stayed tied up in unpaid bills, operating cash flow fell 20.2% from a year ago to $40.9 million, after jumping 77.6% in the second quarter.
Addus paid down another $40.0 million of debt during the quarter, cutting gross bank debt from $64.3 million in June and $154.3 million a year ago (down 84.3% by our math). Combined with $98.5 million in cash, the company now sits in a net cash position with $617.8 million available on its credit line.
Income tax expense took 26.9% of pre-tax profit by our math, matching the second quarter's 26.9% and up from 24.7% a year ago after federal hiring tax credits expired. Diluted share count rose 1.0% from a year ago to 18.57 million shares due to employee stock pay.
❓ Key Questions
What will the AccentCare deal earn, and when does it close?
The $275 million purchase adds $280 million in yearly revenue across Texas, Illinois, California and Arizona, but the release gave no profit margin or closing date. Knowing the division's margin will show how much the deal lifts profit per share after borrowing costs.
Why did Personal Care same-store patient counts slip in Q3?
Same-store Personal Care census dipped by 107 patients from the second quarter to 49,848, down 0.4% from a year ago. Management had aimed for year-over-year patient growth in the second half of 2026, and the Texas 9.9% rate boost is now passing its anniversary.
Why did accounts receivable jump $15.7 million this quarter?
Receivables rose 10.8% from June to $160.9 million, which held operating cash flow below last year's level. Investors need to know whether Illinois or managed-care payers slowed their payments around the September 30 state waiver renewal date.
Did longer hospice stays trigger new Medicare cap penalties?
Average discharged hospice stays rose 21.4% from a year ago to 108.8 days, and reported hospice revenue grew only 0.2% despite a 4.3% rise in daily patients. Management had previously anticipated no new Medicare cap charges in the second half of 2026.